Nausea and Vomiting Induced by Motion Sickness Epidemiology Forecast 2026-2035

Read more about this report - Request a Free Sample

Nausea and Vomiting Induced by Motion Sickness Epidemiology Forecast Report Coverage

Expert Market Research's “Nausea and Vomiting Induced by Motion Sickness Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of nausea and vomiting induced by motion sickness. It projects the future incidence and prevalence rates of nausea and vomiting induced by motion sickness cases across various populations. The study covers age, gender, and type as major determinants of the nausea and vomiting induced by motion sickness population. The report highlights patterns in the prevalence of nausea and vomiting induced by motion sickness over time and projects future trends based on multiple variables.

Nausea and Vomiting Induced by Motion Sickness Understanding: Disease Overview

Nausea and vomiting induced by motion sickness occur when the brain receives conflicting signals from the vestibular system in the inner ear, the eyes, and sensory receptors during motion. This sensory mismatch disrupts balance perception and triggers autonomic responses such as nausea, dizziness, sweating, and vomiting. Motion sickness commonly occurs during travel by car, sea, air, or virtual environments. It can be categorized into different forms, including seasickness, airsickness, carsickness, and simulator sickness. Individuals with heightened vestibular sensitivity, children, and those exposed to prolonged or irregular motion are more susceptible to developing these symptoms.

Nausea and Vomiting Induced by Motion Sickness Epidemiology Perspective

The nausea and vomiting induced by motion sickness epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for nausea and vomiting induced by motion sickness epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for nausea and vomiting induced by motion sickness and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• According to Nicole Jensen et al., 2026, motion sickness affects individuals globally and is a common cause of nausea and vomiting during travel. Nearly all individuals experience it at least once in their lifetime, though many gradually adapt or develop tolerance over time.
• As per Nicole Jensen et al., 2026, age plays a significant role in susceptibility. Motion sickness affects approximately 35%–43% of children before puberty and about 25% of adolescents or young adults, with peak vulnerability occurring between 9 and 10 years of age.
• According to Nicole Jensen et al., 2026, motion sickness is rare in children under 2 years and becomes less frequent with age. It affects 14% of adults below 30 years and about 7% of adults above 60 years, with cases rarely reported after 50 years.
• As per Amitabh Kishor Dwivedi et al., 2024, a study among 562 young adults aged 18–28 years found 71.4% mild, 27.8% moderate, and 0.9% severe motion sickness, indicating substantial prevalence in young adults and measurable impacts on daily functioning.
• According to Nicole Jensen et al., 2026, incidence varies by travel exposure. Seasickness is the most common form, affecting up to 25% of ship passengers, while carsickness occurs in about 4%, train-related motion sickness in 0.13%, and less than 1% in commercial aircraft travelers.

Read more about this report - Request a Free Sample

Country-wise Nausea and Vomiting Induced by Motion Sickness Epidemiology

The nausea and vomiting induced by motion sickness epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Across the regions covered in the report, the epidemiology of nausea and vomiting induced by motion sickness demonstrates notable population susceptibility during travel. According to Vanda Pharmaceuticals, approximately 25–30% of adults in the United States, representing nearly 65–78 million individuals, experience motion sickness symptoms during common travel modes, while 5–15% of the population report severe, recurrent episodes that significantly affect daily functioning. Globally, up to one-third of individuals are highly susceptible. In India, as per Amitabh Kishor Dwivedi et al. (2024), a study among 562 young adults reported 71.4% mild, 27.8% moderate, and 0.9% severe susceptibility, highlighting a substantial burden among the 18–28-year population. Similar susceptibility patterns are reported across Europe and Japan, indicating consistent epidemiological trends in travel-related nausea and vomiting.

Nausea and Vomiting Induced by Motion Sickness: Treatment Overview

Treatment for nausea and vomiting caused by motion sickness focuses on symptom prevention and relief through pharmacological and non-pharmacological approaches. Common medications include antihistamines such as dimenhydrinate and meclizine, anticholinergic agents like scopolamine, and antiemetics used to control nausea and vomiting. Behavioral strategies, including minimizing head movement, focusing on a stable horizon, and selecting stable seating positions during travel, can reduce symptoms. Additional supportive measures include adequate ventilation, hydration, and gradual exposure to motion stimuli. In certain cases, vestibular rehabilitation and preventive medication use prior to travel may improve tolerance to motion.

Key Questions Answered

• What are the key findings of nausea and vomiting induced by motion sickness epidemiology in the 8 major markets?
• What will be the total number of patients with nausea and vomiting induced by motion sickness across the 8 major markets during the forecast period?
• What was the country-wise nausea and vomiting induced by motion sickness epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of nausea and vomiting induced by motion sickness patients during the forecast period of 2026-2035?
• Which key factors would influence the shift in the patient population of nausea and vomiting induced by motion sickness during the forecast period of 2026-2035?
• What are the currently available treatments for nausea and vomiting induced by motion sickness?
• What are the risks, signs, symptoms, and unmet needs of nausea and vomiting induced by motion sickness?

Scope of the Nausea and Vomiting Induced by Motion Sickness Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of nausea and vomiting induced by motion sickness based on several factors.
• Nausea and Vomiting Induced by Motion Sickness Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The nausea and vomiting induced by motion sickness report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Motion Sickness Drugs Market

Post-Operative Nausea & Vomiting Epidemiology Forecast